The Schedule of Pharmaceutical Benefits was updated on 01 Dec 2015 In addition, ex-manufacturer pricing, formulary allocations, drugs subject to price disclosure, therapeutic relativity information, pharmacy remuneration and regulation, the eculizumab reference group, PBAC summary documents July 2015 and review, DUSC outcomes and OTC products for de-listing or amendment are also included.
Click here to view the Summary of Changes.
Source: pharmacydaily.com.au, Wednesday 2 December 2015